Browse publications on Google Scholar (top-right) ↗
Resume (English only)
Academic Achievements
Winner of the Eureka Prize for Leadership and Innovation in Science in 2022; ranked #1 researcher globally on Respiratory Protective Devices as of early 2024 (Expertscape); highly ranked in Smallpox and several other areas of infectious diseases; H index of 81/64 (GS/Scopus) with over 30,000 citations; FWCI: 3.69 since 2011, 4.7 since 2020, 30.46 for topic influenza, 18.8 citations per publication in the past 5 years; 21.4% of her publications are in the top 10% most cited papers (Scopus) in the last 5 years.
Research Experience
She is a NHMRC Leadership 3 Fellow and Professor of Global Biosecurity, heading the Biosecurity Program at the Kirby Institute, which conducts research in epidemiology, bioinformatics, health intelligence, vaccinology, bioterrorism prevention, mathematical modelling, genetic epidemiology, public health, and clinical trials in infectious diseases. She conceived and developed EPIWATCH®️, an advanced AI system for real-time global health intelligence from 2016 onwards.
Education
MBBS Hons 1, FRACP, FAFPHM, M App Epid, PhD
Background
Her expertise covers emerging infectious diseases, infection, biosecurity, biodefense, influenza, vaccines, adult and elderly vaccination, epidemiology, epidemic control, pandemics, travel and border control, HPV, pneumococcal disease, bioterrorism, smallpox, mpox, anthrax, Ebola, viral haemorrhagic fevers, MERS coronavirus, COVID-19, H5N1, avian influenza, health security, health intelligence, modelling, clinical trials, study design, big data, precision harm, and artificial intelligence for epidemic detection.
Miscellany
Member of the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC 2021-2024), WHO SAGE ad-hoc Working Group on Smallpox and Monkeypox, and focal point for WHO GOARN in the UNSW GOARN member group.